HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review

Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury

(2011) M Pirmohamed et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans

(2011) Sae-Hoon Kim et al.   EPILEPSY RESEARCH

Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients

(2011) Yan Zhang et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population

(2011) Choong-Chor Chang et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Drug hypersensitivity: Pharmacogenetics and clinical syndromes

(2011) Elizabeth J. Phillips et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan

(2011) Pei Chen et al.   NEW ENGLAND JOURNAL OF MEDICINE

HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans

(2011) Mark McCormack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association between HLA-B*1502 allele and carbamazepine-induced severe cutaneous adverse reactions in Han people of southern China mainland

(2011) Qian Wang et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain

(2011) Kongkiat Kulkantrakorn et al.   Pain Practice

HLA-B* 1502 screening: Time to clinical practice

(2010) Chaichon Locharernkul et al.   EPILEPSIA

HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients

(2010) Nahoko Kaniwa et al.   EPILEPSIA

Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population

(2010) Wichittra Tassaneeyakul et al.   EPILEPSIA

Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China

(2010) X.T. Wu et al.   EPILEPSY & BEHAVIOR

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

(2010) Takeshi Ozeki et al.   HUMAN MOLECULAR GENETICS

Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients

(2010) Mariko KASHIWAGI et al.   JOURNAL OF DERMATOLOGY

HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions

(2009) Hiroko Ikeda et al.   EPILEPSIA

Association of HLA-BFNx011502 allele and carbamazepine-inducedStevens-Johnson syndromeamong Indians

(2009) TimirY Mehta et al.   Indian Journal of Dermatology Venereology & Leprology

Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population

(2008) Chaichon Locharernkul et al.   EPILEPSIA

HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis

(2008) Nahoko Kaniwa et al.   PHARMACOGENOMICS

Carbamazepine,HLA-B*1502and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations

(2008) P Brent Ferrell et al.   PHARMACOGENOMICS

Methodological quality of pharmacogenetic studies: Issues of concern

(2008) Andrea L. Jorgensen et al.   STATISTICS IN MEDICINE